Method for Efficient Transduction of Cancer Stem Cells

Kiera Walker1, Anita Hjelmeland1

  • 1Department of Cell, Developmental and Integrative Biology; University of Alabama at Birmingham; Birmingham, Alabama 35294; USA.

Journal of Cancer Stem Cell Research
|August 23, 2016
PubMed

Insights

This study introduces CSC293Ts, a cell line that efficiently produces lentivirus in serum-free media. This overcomes challenges in gene expression and silencing in cancer stem cells (CSCs), improving molecular pathway research.

Area of Science:

  • Molecular Biology
  • Virology
  • Cancer Research

Background:

  • Ectopic gene expression and gene silencing are crucial for studying molecular pathways.
  • Lentivirus-based systems offer high infection rates, beneficial for cells with low transfection efficiency, such as glioblastoma cancer stem cells (CSCs).
  • Existing methods face challenges, including the need to eliminate fetal bovine serum (FBS), which can induce differentiation.

Purpose of the Study:

  • To develop a lentivirus production system that functions effectively in serum-free media suitable for CSCs.
  • To overcome technical limitations hindering the use of lentivirus for gene manipulation in CSCs.
  • To provide protocols for generating and utilizing this system for glioblastoma research.

Main Methods:

  • Generation of a 293T cell subline (CSC293Ts) capable of viral production in CSC media.
  • Detailed protocols for CSC293T generation and lentivirus production.
  • Infection of glioblastoma cells using lentivirus produced in serum-free conditions.

Main Results:

  • CSC293Ts efficiently produce lentivirus in serum-free media.
  • Achieved infection rates exceeding 80% in glioblastoma cells without the need for virus concentration.
  • Demonstrated the utility of the system in a glioblastoma model.

Conclusions:

  • The CSC293T cell line and associated protocols facilitate high-efficiency lentiviral gene transfer in CSCs using serum-free conditions.
  • This system simplifies experimental design and broadens the applicability of lentivirus technology for CSC research.
  • The provided protocols are adaptable for various cell types, offering wide utility.